1. Home
  2. KLTR vs INBX Comparison

KLTR vs INBX Comparison

Compare KLTR & INBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kaltura Inc.

KLTR

Kaltura Inc.

HOLD

Current Price

$1.71

Market Cap

238.4M

Sector

Technology

ML Signal

HOLD

Logo Inhibrx Inc.

INBX

Inhibrx Inc.

HOLD

Current Price

$78.47

Market Cap

430.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KLTR
INBX
Founded
2006
2010
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
238.4M
430.2M
IPO Year
2021
2020

Fundamental Metrics

Financial Performance
Metric
KLTR
INBX
Price
$1.71
$78.47
Analyst Decision
Strong Buy
Hold
Analyst Count
2
2
Target Price
$3.50
N/A
AVG Volume (30 Days)
324.8K
242.8K
Earning Date
11-10-2025
11-14-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$180,921,000.00
$1,400,000.00
Revenue This Year
$3.10
$563.00
Revenue Next Year
$1.08
N/A
P/E Ratio
N/A
N/A
Revenue Growth
1.88
N/A
52 Week Low
$1.36
$10.81
52 Week High
$2.82
$94.57

Technical Indicators

Market Signals
Indicator
KLTR
INBX
Relative Strength Index (RSI) 54.98 47.65
Support Level $1.64 $76.22
Resistance Level $1.73 $81.79
Average True Range (ATR) 0.08 6.66
MACD 0.00 -1.37
Stochastic Oscillator 52.38 19.98

Price Performance

Historical Comparison
KLTR
INBX

About KLTR Kaltura Inc.

Kaltura Inc provides live and on-demand video SaaS solutions to thousands of organizations around the world, engaging hundreds of millions of viewers at home, at work, and at school. It also offers specialized industry solutions, including Learning Management System Video, Lecture Capture, and Virtual Classroom for educational institutions, as well as a TV Solution for media and telecom companies. It operates in two reporting segments which are Enterprise, Education, and Technology, and Media and Telecom. The majority of the revenue is derived from Enterprise, Education & Technology. The majority of the revenue is earned from the United States.

About INBX Inhibrx Inc.

Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.

Share on Social Networks: